Pseudosubstrate Peptides Inhibit Akt and Induce Cell Growth Inhibition
- 15 January 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (5) , 1254-1263
- https://doi.org/10.1021/bi034515p
Abstract
We have designed peptide inhibitors that potently inhibit Akt both in vitro and inside cells. These peptide inhibitors are selective for Akt versus other closely related kinases. The peptides inhibit the in vitro phosphorylation of a biotinylated Bad peptide by Akt with potency up to 100 nM. We have shown that the binding between Akt1 and these peptide inhibitors requires MgATP. Mutating the two putative Akt phosphorylation sites to Ala (nonsubstrate) in these peptides increases the inhibitory potency while mutating the sites to aspartic acid (phosphorylation mimetic) reduces the potency. When delivered into cells, these peptide inhibitors can inhibit cellular Akt activity and cell growth. Thus, these Akt-specific peptide inhibitors provide prototypes for peptide mimetic drugs as well as very useful tools to dissect cellular functions of Akt.Keywords
This publication has 20 references indexed in Scilit:
- Crystal Structure of an Inactive Akt2 Kinase DomainStructure, 2003
- Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 FunctionJournal of Biological Chemistry, 2002
- Induction of ovarian cancer by defined multiple genetic changes in a mouse model systemCancer Cell, 2002
- Peptide and Protein Library Screening Defines Optimal Substrate Motifs for AKT/PKBJournal of Biological Chemistry, 2000
- Protein Kinase B Regulates T Lymphocyte Survival, Nuclear Factor κb Activation, and Bcl-XL Levels in VivoThe Journal of Experimental Medicine, 2000
- Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic eraChemistry & Biology, 1999
- Amplification and overexpression of theAKT2 oncogene in a subset of human pancreatic ductal adenocarcinomasMolecular Carcinogenesis, 1998
- Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1997
- Amplification of 19q13.1–q13.2 sequences in ovarian cancerCancer Genetics and Cytogenetics, 1996
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995